OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VILR.AT57

Unibios Holdings SA

Environmental Services & EquipmentVerified

Unibios Holdings SA has a debt-to-equity ratio of 0.55, indicating a relatively balanced capital structure with moderate leverage. The company holds €6.28 million in cash and equivalents, but its long-term debt of €10.24 million suggests a net cash position that is negative after subtracting total debt. This liquidity profile is categorized as medium risk, with the company maintaining sufficient cash to cover short-term obligations but limited buffer against unexpected capital needs. Profitability metrics show mixed performance. The company reported an operating cash flow of €546,050, which is modest given its revenue of €13.89 million. This suggests that while the company is generating positive cash flow, it is not doing so at a rate that significantly outpaces industry norms. The return on invested capital (ROIC) and other profitability ratios are not provided, but the low operating cash flow relative to revenue indicates that the company may be underperforming in terms of capital efficiency compared to industry peers. Geographically, Unibios operates through subsidiaries in five European countries and is active in the Middle East and Africa. However, the company's revenue concentration is not disclosed, making it difficult to assess the risk associated with geographic exposure. The company's main operating division, Watera International, is the primary revenue driver, but the contribution of other subsidiaries such as Biossol SA and Culligan Hellas is not quantified. The company's growth trajectory is uncertain. While it has a revenue of €13.89 million, there is no indication of year-over-year growth or future projections. The capital expenditure of -€2.15 million suggests that the company is not investing heavily in new projects or expansion, which could limit its ability to grow in the coming years. The outlook for the current and next fiscal years is not provided, but the lack of significant capital investment may indicate a conservative or stagnant growth strategy. Risk factors include medium liquidity risk and low dilution potential. The company's liquidity risk is primarily due to its negative net cash position after accounting for long-term debt. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat from stock options or convertible securities. However, the company's capital structure and cash flow dynamics suggest that it may need to raise additional capital in the future, which could introduce new risks. Recent events and filings do not provide specific details on new projects, partnerships, or strategic initiatives. The company's 10-K filing does not mention any significant recent developments, and there are no transcripts from recent earnings calls or investor presentations that would provide insight into management's strategy or performance.

30-day price · VILR.AT(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyUnibios Holdings SA
TickerVILR.AT
SectorIndustrials
BusinessIndustrial & Commercial Services
Industry groupIndustrial & Commercial Services
IndustryEnvironmental Services & Equipment
AI analysis

Business. Unibios Holdings SA develops, installs, and maintains desalination and filtering solutions for municipalities, manufacturing, power generation, and hospitality industries, primarily through its Watera International division.

Classification. Unibios is classified in the Environmental Services & Equipment industry under the Industrial & Commercial Services business sector, with a confidence level of 0.92.

Unibios Holdings SA has a debt-to-equity ratio of 0.55, indicating a relatively balanced capital structure with moderate leverage. The company holds €6.28 million in cash and equivalents, but its long-term debt of €10.24 million suggests a net cash position that is negative after subtracting total debt. This liquidity profile is categorized as medium risk, with the company maintaining sufficient cash to cover short-term obligations but limited buffer against unexpected capital needs. Profitability metrics show mixed performance. The company reported an operating cash flow of €546,050, which is modest given its revenue of €13.89 million. This suggests that while the company is generating positive cash flow, it is not doing so at a rate that significantly outpaces industry norms. The return on invested capital (ROIC) and other profitability ratios are not provided, but the low operating cash flow relative to revenue indicates that the company may be underperforming in terms of capital efficiency compared to industry peers. Geographically, Unibios operates through subsidiaries in five European countries and is active in the Middle East and Africa. However, the company's revenue concentration is not disclosed, making it difficult to assess the risk associated with geographic exposure. The company's main operating division, Watera International, is the primary revenue driver, but the contribution of other subsidiaries such as Biossol SA and Culligan Hellas is not quantified. The company's growth trajectory is uncertain. While it has a revenue of €13.89 million, there is no indication of year-over-year growth or future projections. The capital expenditure of -€2.15 million suggests that the company is not investing heavily in new projects or expansion, which could limit its ability to grow in the coming years. The outlook for the current and next fiscal years is not provided, but the lack of significant capital investment may indicate a conservative or stagnant growth strategy. Risk factors include medium liquidity risk and low dilution potential. The company's liquidity risk is primarily due to its negative net cash position after accounting for long-term debt. The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted shares, indicating no imminent threat from stock options or convertible securities. However, the company's capital structure and cash flow dynamics suggest that it may need to raise additional capital in the future, which could introduce new risks. Recent events and filings do not provide specific details on new projects, partnerships, or strategic initiatives. The company's 10-K filing does not mention any significant recent developments, and there are no transcripts from recent earnings calls or investor presentations that would provide insight into management's strategy or performance.
Key takeaways
  • Unibios Holdings SA has a balanced capital structure with a debt-to-equity ratio of 0.55.
  • The company's operating cash flow is modest relative to its revenue, indicating potential inefficiencies in capital use.
  • Geographic exposure is broad but revenue concentration is not disclosed, making it difficult to assess regional risk.
  • Growth appears to be limited, with no significant capital investment and no clear revenue growth trajectory.
  • Liquidity risk is medium, and dilution risk is low, but the company may need to raise additional capital in the future.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue$13.9M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow$546.0k
CapEx-$2.1M
Free cash flow
Total assets
Total liabilities$18.1M
Total equity$18.7M
Cash & equivalents$6.3M
Long-term debt$10.2M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash-$4.0M
Current ratio
Debt/Equity0.6
ROA
ROE
Cash conversion
CapEx/Revenue-15.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Industrial Services · cohort 6 companies
MetricVILR.ATActivity
Op margin11.2% medp25 7.1% · p75 18.5%
Net margin13.8% medp25 13.8% · p75 13.8%
Gross margin94.7% medp25 62.9% · p75 126.4%
R&D / revenue6.0% medp25 6.0% · p75 6.0%
CapEx / revenue-15.5%6.7% medp25 4.4% · p75 7.4%bottom quartile
Debt / equity55.0%136.7% medp25 101.5% · p75 217.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:19 UTC#ace3e965
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:22 UTCJob: 904d46f7